FDA issued a warning letter to Professional Compounding Centers of America Inc. (PCCA) for receiving and distributing adulterated and misbranded active pharmaceutical ingredients (APIs).
Similar Posts
CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)Draft pageNotable Approvals | Drugs
News about human drug-related approvalsEugia Pharma Specialities Limited – 2/6/2026
Eugia Pharma Specialities Limited – 2/6/2026. Country: India. Record Type: 483CDER Data Standards Program
CDER Data Standards ProgramAquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk
August 28, 2025, AquaStar (USA) Corp of Seattle, WA is recalling approximately 26,460 packages of Cocktail Shrimp 6oz (see photo), imported from Indonesia, because they may have been prepared, packed, or held under insanitary conditions whereby they may have become contaminated with cesium-137 (Cs-1Hofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk
Hofood99 Inc of Brooklyn, NY 11231 is recalling its 200g packages of Enoki Mushroom, because they may be contaminated with Listeria monocytogenes